Companies / Skye Bioscience, Inc.

Skye Bioscience, Inc.

Nasdaq: SKYECIK 1516551SAN DIEGO, CA

Financials

Revenue—
Net income$-55.92M
Total debt$116.7K
Cash$8.15M
Diluted EPS$-1.41
Shares outstanding35.1M

Ownership

35.1M shares outstanding · as of May 8, 2026
45.9%Institutions
Ownership
Institutions45.88%16,124,740
Public float54.12%19,018,982

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Arora Puneet S.FormerChief Medical Officer
——
Arsenault KaitlynChief Financial Officer
——
Charych Deborah H.Director
——
Dhillon PunitCEOChief Executive Officer · Director
——
Diep Tuan TuFormerChief Development Officer
——
Grayson Paul A.Director
——
Jenkins AnnalisaDirector
——
Schwab Andrew J.Director
——
Sharp John PFormerChief Financial Officer
——
Smith Karen L.Director
——

Institutional holders 50

View all →
HolderValue% of shares
5AM Venture Management, LLC$7.26M27.55%
Versant Venture Management, LLC$1.51M5.71%
Baker Bros. Advisors LP$968.1K4.48%
Vanguard Group Inc$662.1K2.51%
Sphera Funds Management Ltd.$359.1K1.36%
Geode Capital Management, LLC$170.4K0.79%
BlackRock, Inc.$161.5K0.66%
Millennium Management LLC$158.7K0.73%
Platinum Investment Management Ltd$143.3K0.66%
Schonfeld Strategic Advisors LLC$70.0K0.27%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 6, 2026Smith Karen L.
Director
GrantStock Option (Right to Buy)—+35K
35,000
0.10% of shares
low
Feb 6, 2026Jenkins Annalisa
Director
GrantStock Option (Right to Buy)—+35K
35,000
0.10% of shares
low
Feb 6, 2026Schwab Andrew J.
Director
GrantStock Option (Right to Buy)—+35K
35,000
0.10% of shares
low
Feb 6, 2026Grayson Paul A.
Director
GrantStock Option (Right to Buy)—+35K
35,000
0.10% of shares
low
Feb 6, 2026Arsenault Kaitlyn
Executive
GrantStock Option (Right to Buy)—+125K
125,000
0.36% of shares
low
Feb 6, 2026Twitty Christopher
Executive
GrantStock Option (Right to Buy)—+150K
150,000
0.43% of shares
low
Feb 6, 2026Charych Deborah H.
Director
GrantStock Option (Right to Buy)—+35K
35,000
0.10% of shares
low
Feb 6, 2026Diep Tuan Tu
Executive
GrantStock Option (Right to Buy)—+125K
125,000
0.36% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SKYECommon StockEquity83086J200BBG00433GZN1